305 related articles for article (PubMed ID: 18027261)
21. International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy.
Christensen TD; Larsen TB; Jensen C; Maegaard M; Sørensen B
Thromb Haemost; 2009 Mar; 101(3):563-9. PubMed ID: 19277421
[TBL] [Abstract][Full Text] [Related]
22. Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method.
Taborski U; Braun SL; Völler H
J Thromb Thrombolysis; 2004 Oct; 18(2):103-7. PubMed ID: 15789176
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H
Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
[TBL] [Abstract][Full Text] [Related]
24. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC
Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the CoaguChek XS handheld coagulation analyzer and conventional laboratory methods measuring international normalised ratio (INR) values during the time to therapeutic range after mechanical valve surgery.
Bardakci H; Altıntaş G; Çiçek OF; Kervan U; Yilmaz S; Kaplan S; Birincioglu CL
J Card Surg; 2013 May; 28(3):254-7. PubMed ID: 23578221
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of CoaguChek XS for measuring prothrombin time in patients receiving long-term oral anticoagulant therapy].
Lee JH; Lee KS; Kim DS; Lee HS; Choi SI; Cho YG
Korean J Lab Med; 2007 Jun; 27(3):177-81. PubMed ID: 18094572
[TBL] [Abstract][Full Text] [Related]
27. Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years' experience.
Kitchen DP; Kitchen S; Jennings I; Woods TA; Fitzmaurice DA; Murray ET; Walker ID
J Clin Pathol; 2012 Dec; 65(12):1119-23. PubMed ID: 23038688
[TBL] [Abstract][Full Text] [Related]
28. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
Fonseca MES; Balbi GGM; Signorelli F; Gouvea CP; de Andrade DCO
Lupus; 2022 Apr; 31(5):565-574. PubMed ID: 35266798
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the INR Values Measured by CoaguChek XS Coagulometer and Conventional Laboratory Methods in Patients on VKA Therapy.
Kalçık M; Yesin M; Gürsoy MO; Gündüz S; Karakoyun S; Astarcıoğlu MA; Bayam E; Cerşit S; Özkan M
Clin Appl Thromb Hemost; 2017 Mar; 23(2):187-194. PubMed ID: 26177662
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Roche CoaguChek XS handheld coagulation analyzer in a cardiac outpatient clinic.
Nam MH; Roh KH; Pak HN; Lee CK; Kim YH; Lee KN; Cho Y
Ann Clin Lab Sci; 2008; 38(1):37-40. PubMed ID: 18316780
[TBL] [Abstract][Full Text] [Related]
31. Validation of the CoaguChek XS international normalised ratio point-of-care analyser in patients at Charlotte Maxeke Johannesburg Academic Hospital, South Africa.
Benade EL; Jacobson BF; Louw S; Schapkaitz E
S Afr Med J; 2016 Feb; 106(3):280-3. PubMed ID: 26915943
[TBL] [Abstract][Full Text] [Related]
32. Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic.
Colella MP; Fiusa MM; Orsi FL; de Paula EV; Annichino-Bizzacchi JM
Blood Coagul Fibrinolysis; 2012 Mar; 23(2):172-4. PubMed ID: 22246165
[TBL] [Abstract][Full Text] [Related]
33. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring.
Gardiner C; Williams K; Mackie IJ; Machin SJ; Cohen H
Br J Haematol; 2005 Jan; 128(2):242-7. PubMed ID: 15638860
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the CoaguChek XS Plus system in a Swiss community setting.
Deom A; Reber G; Tsakiris DA; Hannes FM; Plesch W
Thromb Haemost; 2009 May; 101(5):988-90. PubMed ID: 19404558
[No Abstract] [Full Text] [Related]
36. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
Jonsson M; Hillarp A; Svensson P
Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of point-of-care vs laboratory measurement of anticoagulation.
Sunderji R; Gin K; Shalansky K; Carter C; Chambers K; Davies C; Schwartz L; Fung A
Am J Clin Pathol; 2005 Feb; 123(2):184-8. PubMed ID: 15842040
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of international normalized ratio determined by portable venous-blood coagulation monitor versus a central laboratory.
Sirithunyanont C; Bhuripanyo K; Kangkagate C; Winyarat W; Srichaya P; Wangtip K
J Med Assoc Thai; 2003 May; 86 Suppl 1():S67-75. PubMed ID: 12866771
[TBL] [Abstract][Full Text] [Related]
39. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing.
Bonar R; Mohammed S; Favaloro EJ
Semin Thromb Hemost; 2015 Apr; 41(3):279-86. PubMed ID: 25839866
[TBL] [Abstract][Full Text] [Related]
40. Precision and accuracy of CoaguChek S and XS monitors: the need for external quality assessment.
Poller L
Thromb Haemost; 2009 Mar; 101(3):419-21. PubMed ID: 19277400
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
